Ingevity (FRA:IGX) Beneish M-Score: -2.99 (As of Jun. 25, 2026)


FRA:IGX Ingevity Corp FRA:IGX
65 GF Score
Price €63.50
GF Value €38.18
! 6 Warning Signs
View Full Analysis

What is Ingevity Beneish M-Score?

Ingevity FRA:IGX +2.42% 65 Beneish M-Score is -2.99 as of Jun. 25, 2026. GuruFocus rates FRA:IGX with a GF Score™ of 65/100 and a GF Value™ of €38.18. The stock has 6 warning signs investors should review. Among 1,529 Chemicals companies, Ingevity ranks better than 84.96% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.99 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Ingevity's Beneish M-Score or its related term are showing as below:

FRA:IGX' s Beneish M-Score Range Over the Past 10 Years
Min: -3.15   Med: -2.66   Max: -1.94
Current: -2.99

During the past 13 years, the highest Beneish M-Score of Ingevity was -1.94. The lowest was -3.15. And the median was -2.66.


Ingevity Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Ingevity's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ingevity Beneish M-Score Chart

Ingevity Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.49 -2.28 -2.96 -2.84 -3.15

Ingevity Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.94 -3.13 -2.90 -3.15 -2.99

FRA:IGX vs MTX, KWR, ASH: Beneish M-Score Comparison

For the Specialty Chemicals subindustry, Ingevity's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ingevity Beneish M-Score vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Ingevity's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Ingevity's Beneish M-Score falls into.


FRA:IGX
65GF Score
Ingevity Corp FRA:IGX
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ingevity Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Ingevity for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9492+0.528 * 0.9603+0.404 * 0.6529+0.892 * 0.91+0.115 * 0.9218
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0891+4.679 * -0.040951-0.327 * 1.1607
=-3.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was €131 Mil.
Revenue was 223.17 + 217.855 + 283.801 + 316.542 = €1,041 Mil.
Gross Profit was 100.686 + 74.981 + 114.083 + 119.559 = €409 Mil.
Total Current Assets was €503 Mil.
Total Assets was €1,427 Mil.
Property, Plant and Equipment(Net PPE) was €550 Mil.
Depreciation, Depletion and Amortization(DDA) was €90 Mil.
Selling, General, & Admin. Expense(SGA) was €147 Mil.
Total Current Liabilities was €354 Mil.
Long-Term Debt & Capital Lease Obligation was €960 Mil.
Net Income was 51.727 + -72.248 + 37.062 + -127.015 = €-110 Mil.
Non Operating Income was -19.895 + -108.8 + -1.704 + -181.81 = €-312 Mil.
Cash Flow from Operations was -1.73 + 82.923 + 110.504 + 68.493 = €260 Mil.
Total Receivables was €151 Mil.
Revenue was 229.307 + 251.452 + 300.754 + 362.867 = €1,144 Mil.
Gross Profit was 103.507 + 95.405 + 118.572 + 114.453 = €432 Mil.
Total Current Assets was €490 Mil.
Total Assets was €1,902 Mil.
Property, Plant and Equipment(Net PPE) was €649 Mil.
Depreciation, Depletion and Amortization(DDA) was €96 Mil.
Selling, General, & Admin. Expense(SGA) was €148 Mil.
Total Current Liabilities was €245 Mil.
Long-Term Debt & Capital Lease Obligation was €1,263 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(130.788 / 1041.368) / (151.422 / 1144.38)
=0.125592 / 0.132318
=0.9492

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(431.937 / 1144.38) / (409.309 / 1041.368)
=0.377442 / 0.393049
=0.9603

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (503.257 + 550.486) / 1427.423) / (1 - (490.25 + 649.072) / 1901.892)
=0.261786 / 0.400953
=0.6529

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1041.368 / 1144.38
=0.91

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(96.066 / (96.066 + 649.072)) / (89.513 / (89.513 + 550.486))
=0.128924 / 0.139864
=0.9218

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(146.625 / 1041.368) / (147.943 / 1144.38)
=0.1408 / 0.129278
=1.0891

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((959.717 + 354.131) / 1427.423) / ((1263.457 + 244.755) / 1901.892)
=0.920434 / 0.793006
=1.1607

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-110.474 - -312.209 - 260.19) / 1427.423
=-0.040951

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Ingevity has a M-score of -3.04 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.99 mean?
Ingevity (FRA:IGX) has a Beneish M-Score of -2.99 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Ingevity and its competitors. According to the industry distribution chart, Ingevity ranks #230 out of 1529 companies in the Chemicals industry, placing it in the top 15%.
Is Ingevity's Beneish M-Score too high?
Ingevity's current Beneish M-Score is -2.99. Based on the distribution chart, Ingevity ranks #230 out of 1529 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Ingevity has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Ingevity's Beneish M-Score compare to MTX and KWR?
According to the Chemicals industry distribution chart, Ingevity ranks #230 out of 1529 companies for Beneish M-Score. This places Ingevity in the top 15% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Chemicals company?
A good Beneish M-Score depends on the Chemicals industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Ingevity and its competitors. Ingevity's current Beneish M-Score is -2.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ingevity stock overvalued right now?
Ingevity (FRA:IGX) has a current Beneish M-Score of -2.99. The stock's GF Value™ is €38.18, compared to a current price of €63.50 — trading 66.3% above its estimated fair value. The current Beneish M-Score is -2.99. Ingevity's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Ingevity (FRA:IGX), the current Beneish M-Score is -2.99 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ingevity (FRA:IGX) Overvalued in 2026?

Based on GuruFocus' analysis, Ingevity stock appears to be overvalued. The current stock price of €63.50 is trading 66.3% above its estimated GF Value™ of €38.18.

Key valuation signals for FRA:IGX:

  • Beneish M-Score: -2.99
  • GF Value™: €38.18 vs. price of €63.50 (66.3% above fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the FRA:IGX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ingevity Business Description

Other Exchanges NGVT:USAIGX:Germany
Address 4920 O\'Hear Avenue, Suite 400, North Charleston, SC, USA, 29405
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.
65GF Score

Get the complete analysis for FRA:IGX

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€63.50
Price
€38.18
GF Value